Completed
Phase 3
Age: 30Years - 69Years
All Genders
ID00000491
Aspirin-Myocardial Infarction Study (AMIS)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-03-25
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.
CONDITIONS
Brief Title
Aspirin-Myocardial Infarction Study (AMIS)
Who Can Participate
Age: 30Years - 69Years
All Genders
Eligibility Criteria
Men and women, ages 30 to 69. Had a documented myocardial infarction.
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here